# Use of Ranibizumab to Treat Rubeosis in Diabetics Prior to Cataract Surgery

> **NCT01069341** · PHASE1 · COMPLETED · sponsor: **Bhagat, Neelakshi, M.D., M.P.H.** · enrollment: 4 (actual)

## Conditions studied

- Rubeosis Iridis
- Proliferative Diabetic Retinopathy

## Interventions

- **DRUG:** Ranibizumab

## Key facts

- **NCT ID:** NCT01069341
- **Lead sponsor:** Bhagat, Neelakshi, M.D., M.P.H.
- **Sponsor class:** INDIV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2011-12
- **Final completion:** 2012-01
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2012-10-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01069341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01069341, "Use of Ranibizumab to Treat Rubeosis in Diabetics Prior to Cataract Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01069341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*